| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Jazz Pharmaceuticals Plc (JAZZ) has 19 insiders with recent SEC Form 4 filings, including 2 buys and 13 sells. JAZZ is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.18M | $272.39M | - | |
| Dir | 390.7K | $89.95M | - | |
| CEO | 152.2K | $35.04M | - | |
| VP | 72.6K | $16.72M | - | |
| CFO | 59.6K | $13.72M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 25, 2016 | Mulligan Seamus | Director | Sell | 27,968 | $128.32 | $3,588,787.11 | -0.7% | |
| Aug 16, 2016 | Treacy Paul | SVP, Technical Operations | Sell | 1,292 | $137.47 | $177,608.62 | -4.4% | |
| Aug 15, 2016 | Winningham Rick E64 | Director | Sell | 633 | $136.45 | $86,372.85 | -4.0% | |
| Aug 15, 2016 | Sohn Catherine A.55 | Director | Sell | 633 | $136.45 | $86,372.85 | -9.4% | |
| Aug 15, 2016 | Riedel Norbert G63 | Director | Sell | 633 | $136.45 | $86,372.85 | -11.3% | |
| Aug 15, 2016 | McSharry Heather Ann61 | Director | Sell | 685 | $136.45 | $93,468.25 | -10.1% | |
| Aug 15, 2016 | Enright Patrick G74 | Director | Sell | 633 | $136.45 | $86,372.85 | -23.7% | |
| Aug 15, 2016 | Berns Paul L | Director | Sell | 633 | $136.45 | $86,372.85 | -10.8% | |
| Aug 15, 2016 | Miller Michael Patrick46 | SVP, Us Commercial | Sell | 100 | $136.45 | $13,645.00 | -0.6% | |
| Aug 12, 2016 | Smith Karen L. | Global Head Of R&D And CMO | Buy | 608 | $137.10 | $83,355.51 | +2.2% |